Finlands Akademi  
 
 
 
 
 
Finansieringsbeslut
 
Sökande / Kontakt person Kidron, Heidi
Organisation Helsingfors universitet
Projektets titel Precision medicine for CNS drug targeting - phenotypic characterization of BCRP and P-glycoprotein genetic variants.
Beslutnr 332949
Beslutsdatum 27.05.2020
Finansierings period 01.09.2020 - 31.12.2024
Finansiering 497 816
   
Beskrivning av projektet
Drug delivery to the brain and central nervous system is limited by efflux transporters in the blood-brain barrier. The two main efflux transporters recognize a wide variety of drug substrates and are therefore key obstacles in delivering drugs to the brain. Genetic variation can affect the functionality of the transporters, and our hypothesis is that drugs that are normally prevented from entering the brain by these transporters would be able to reach much higher brain concentrations in patients with transporter variants that have low activity. Our aim is thus to establish how genetic variation in these efflux transporters impact drug exposure, and evaluate if this can be used to improve drug treatment in adults. Our studies will also generate data that helps us understand the molecular basis for substrate recognition and transport, which is a second aim of this project.